CAPECITABINE TARO 500 MG

البلد: إسرائيل

اللغة: الإنجليزية

المصدر: Ministry of Health

العنصر النشط:

CAPECITABINE

متاح من:

TARO INTERNATIONAL LTD, ISRAEL

ATC رمز:

L01BC06

الشكل الصيدلاني:

FILM COATED TABLETS

تركيب:

CAPECITABINE 500 MG

طريقة التعاطي:

PER OS

نوع الوصفة الطبية :

Required

المصنعة من قبل:

SUN PHARMACEUTICAL INDUSTRIES LTD., INDIA

المجال العلاجي:

CAPECITABINE

الخصائص العلاجية:

Adjuvant Colon Cancer: Capecitabine Taro 500mg is indicated for the adjuvant treatment of patients following surgery of stage III (Dukes stage C) colon cancer. Colorectal Cancer: Capecitabine Taro 500mg is indicated for the treatment of patients with advanced or metastatic colorectal cancer. Advanced gastric cancer: Capecitabine Taro 500mg is indicated for first line treatment of advanced gastric cancer in combination with chemotherapy. Breast Cancer Combination Therapy: Capecitabine Taro 500mg in combination with docetaxel is indicated for the treatment of patients with metastatic breast cancer after failure of prior anthracycline-containing chemotherapy. Breast Cancer Monotherapy: Capecitabine Taro 500mg is also indicated for the treatment of advanced or metastatic breast cancer after failure of standard therapy including a taxane unless therapy with a taxane is clinically contraindicated.

تاريخ الترخيص:

2022-01-31

نشرة المعلومات

Capecitabine PIL – ENG – Notification –April 2022
Page 1 of 8
PATIENT PACKAGE INSERT IN ACCORDANCE WITH
THE PHARMACISTS
’
REGULATIONS (PREPARATIONS)
– 1986
The medicine is dispensed with a doctor’s prescription only
CAPECITABINE TARO 500 MG
FILM-COATED TABLETS
COMPOSITION:
Each film-coated tablet contains: capecitabine 500 mg
Inactive ingredients and allergens: see section 2 under “Important
information about some of
the ingredients of the medicine” and section 6 “Further
Information”.
READ THE LEAFLET CAREFULLY IN ITS ENTIRETY BEFORE USING THE MEDICINE.
THIS LEAFLET CONTAINS CONCISE INFORMATION ABOUT THE MEDICINE. IF YOU
HAVE FURTHER
QUESTIONS, REFER
TO THE DOCTOR OR PHARMACIST.
•
Keep the leaflet. You may need to read it again.
•
This medicine was prescribed to treat your illness. Do not pass it on
to others. It may
harm them even if it seems to you that their ailment is similar.
•
If you have any side effects, refer to your doctor or pharmacist. This
includes possible
side effects that do not appear in this leaflet (see section 4 –
“Side Effects”).
1)
WHAT IS THE MEDICINE INTENDED FOR?
The medicine, Capecitabine Taro 500 mg, belongs to a group of
medicines called cytostatics,
which stop the development of cancer cells. The medicine itself is not
cytostatic, rather, after
being absorbed in the body, it changes into an active anti-cancer
medicine (more in the
tumor tissue than in normal tissue).
Capecitabine Taro 500 mg is intended for the treatment of breast
cancer after previous
treatments, stomach cancer and colorectal cancer. In addition,
Capecitabine Taro 500 mg is
used to prevent recurrence of colon cancer, after complete surgical
removal of the tumor.
The medicine Capecitabine Taro 500 mg can be taken alone or in
combination with other
medicines.
THERAPEUTIC GROUP: Pyrimidine analogs.
2)
BEFORE USING THE MEDICINE
DO NOT USE THE MEDICINE IF:
•
You are sensitive (allergic) to the active ingredient (capecitabine)
or to any of the
additional ingredients contained in the medic